Sanofi: all 2,424 studies
Page 22 of 25. Open to participants first (105), then studies with results posted, then the rest; newest registration first within each.
- DISCO - Influence of a Simple Information Booklet on the Evolution of Acute Low Back Pain (LBP)CompletedNCT00343057
- Dose Ranging Study in Elective Total Hip Replacement SurgeryCompletedNCT00338897Phase 2/3
- Alfuzosin for Treating Acute Urinary RetentionCompletedNCT00336921Phase 2
- Study of XL647 Administered Orally Daily to Patients With Solid TumorsCompletedNCT00336765Phase 1
- A 24-52-week Study to Evaluate the Long-term Efficacy and Safety of Saredutant in Patients With Depression (MAGENTA)CompletedNCT00336713Phase 3
- I SAVE - Irbesartan in Mild to Moderate Hypertensive PatientsCompletedNCT00335673Phase 4
- Lantus Effect on Myocardial Glucose Metabolism in T2CompletedNCT00335465Phase 4
- Irbesartan in Chinese Hypertensive Diabetics With MicroalbuminuriaCompletedNCT00334581Phase 4
- An Eight-Week Study to Evaluate the Efficacy and Safety of SR58611A in Patients With Generalized Anxiety DisorderCompletedNCT00332891Phase 3
- EFESO - EFficacy Enterogermina Small Intestinal Bacterial OvergrowthCompletedNCT00331994Phase 4
- Amisulpride in Schizophrenic PatientsCompletedNCT00331981Phase 4
- Prevention of Venous Thromboembolism in Patients Undergoing Elective Total Knee Replacement SurgeryCompletedNCT00331838Phase 2
- Study of Sargramostim in Moderately to Severely Active Crohn's DiseaseTerminatedNCT00329537Phase 2
- Combination Study of a New Taxane and Capecitabine in Patients With Metastatic Breast CancerCompletedNCT00327743Phase 1/2
- Ramipril - HypertensionCompletedNCT00325806Phase 4
- Rimonabant In Prediabetic Subjects To Delay Onset Of Type 2 DiabetesTerminatedNCT00325650Phase 3
- Study of Weight-Reducing Effect and Safety of Rimonabant In Obesity in ASIA (RIO-ASIA)CompletedNCT00325546Phase 3
- Efficacy and Safety in Patients With Acute Coronary Syndrome Without ST-Segment ElevationCompletedNCT00325390Phase 3
- Dialysis Clinical Outcomes Revisited (DCOR) TrialCompletedNCT00324571Phase 4
- Study to Compare Once A Day Sevelamer Dosing With Three Times Per Day Sevelamer DosingCompletedNCT00324376Phase 2
- LANCGMS - Lantus Continuous Glucose Monitoring SubcutaneousCompletedNCT00322075Phase 4
- Immunogenicity and Safety of Tetraxim Versus Local DTP + IPVCompletedNCT00319852Phase 3
- An Eight-Week Study to Evaluate the Efficacy and Safety of SR58611A in Elderly Patients With DepressionCompletedNCT00319709Phase 3
- Efficacy, Safety, and Tolerability of Ambien (Zolpidem) in the Treatment of Children Ages 6 to 17 With Attention Deficit Hyperactivity Disorder (ADHD)-Associated InsomniaCompletedNCT00318448Phase 3
- Study of Otamixaban Versus Unfractionated Heparin (UFH) and Eptifibatide in Non-ST Elevation Acute Coronary SyndromeCompletedNCT00317395Phase 2
- ATAQ EASY: Artesunate + Amodiaquine Fixed Dose Combination in the Treatment of Uncomplicated Plasmodium Falciparum MalariaCompletedNCT00316329Phase 3
- TELI TAD - Telithromycin in Tonsillitis in Adolescents and AdultsTerminatedNCT00315549Phase 3
- TELI TON - Telithromycin in TonsillitisTerminatedNCT00315042Phase 3
- TELI COM - Telithromycin in Children With Otitis MediaTerminatedNCT00315003Phase 3
- Immunogenicity and Safety of Hepatitis A Vaccine Given at the Same Time of Measles, Mumps, Rubella Combined VaccineCompletedNCT00313950Phase 4
- SAM - Skip a Meal - Insulin Glargine, Diabetes Mellitus Type 1CompletedNCT00313937Phase 4
- Efficacy and Safety of SR46349B in Patients With Sleep Disorders in FibromyalgiaCompletedNCT00313885Phase 2
- A Study in Patients With Fabry Disease Who Are on Chronic Hemodialysis Therapy for Treatment of End-stage Renal Insufficiency.WithdrawnNCT00312767Phase 4
- Insulin Glargine in Type 2 Diabetes MellitusCompletedNCT00311818Phase 4
- Efficacy and Safety Study of SH T 586 in Combination With Rituximab to Treat Low-Grade NHLCompletedNCT00311129Phase 2
- Bioequipotency Study of Idrabiotaparinux and Idraparinux in Patients With Deep Venous Thrombosis of the Lower LimbsCompletedNCT00311090Phase 3
- Insulin Glulisine in Healthy Lean and Obese SubjectsCompletedNCT00311077Phase 1
- Insulin Glulisine in Type 2 Diabetes MellitusCompletedNCT00310297Phase 1
- Efficacy and Safety of Eplivanserin 5mg/Day on Sleep Maintenance InsomniaCompletedNCT00308503Phase 3
- Evaluation of the Efficacy of Xaliproden (SR57746A) in Preventing the Neurotoxicity of Oxaliplatin / 5FU/LV Chemotherapy.CompletedNCT00305188Phase 3
- Efficacy and Safety Study of Intra-articular Multiple Doses of Icatibant in Patients With Painful Knee OsteoarthritisCompletedNCT00303056Phase 2
- Rasburicase in Tumor Lysis SyndromeCompletedNCT00302653Phase 4
- Mixed Antagonist of Serotonin for Claudication Optimal TherapyCompletedNCT00300339Phase 2
- Dose Ranging Study of the GLP-1 Agonist AVE0010 in Metformin-Treated Subjects With Type 2 Diabetes MellitusCompletedNCT00299871Phase 2
- VIsceral Fat Reduction Assessed by CT-scan On RImonabAntCompletedNCT00299325Phase 3
- Phase 1/1b Dose Escalation Study Evaluating BSI-201 as a Single Agent and in Combination With Irinotecan in Subjects With Advanced Solid TumorsCompletedNCT00298675Phase 1
- Insulin Glulisine in Type 1 Diabetes MellitusCompletedNCT00297583Phase 1
- Immunogenicity of Two Dosages of Inactivated, Split-Virion Influenza Vaccine Given by an Alternate Route in the ElderlyCompletedNCT00296829Phase 2
- PROCLAIM: Study Examining Effects of Clopidogrel Compared to Placebo on Inflammation in Subjects With Metabolic SyndromeCompletedNCT00296803Phase 4
- Ambien CR vs. Placebo For Treatment Of Insomnia Associated With Anxiety When Used Concomitantly With Escitalopram (Lexapro)CompletedNCT00296790Phase 4
- ARCHIPELAGO: Irbesartan in Patients With Acute Coronary Syndrome Without ST Segment ElevationCompletedNCT00296218Phase 3
- Ambien CR For Treatment Of Insomnia Associated With Depression When Used Concomitantly With LexaproCompletedNCT00296179Phase 4
- A New Study to Follow-up Thyroid Cancer Patients Who Participated in a Previous Study, Which Compared the Success of Destruction of the Thyroid Remnant Using Standard Treatment or Thyrogen.CompletedNCT00295763Phase 3
- Efficacy (Induction of Response/Remission) and Safety Study in Patients With Moderate to Severe Crohn's DiseaseTerminatedNCT00295165Phase 3
- A Post-Market Study to Evaluate Adverse Event Incidence Rates in Patients With Skin of Color Undergoing Correction of Nasolabial Folds With Hylaform, Hylaform Plus and Captique.CompletedNCT00293163Phase 4
- Drotaverine in Dysmenorrhoea TreatmentTerminatedNCT00292747Phase 4
- STILDEP: Zolpidem in Depressive and Dysthimic PatientsCompletedNCT00292734Phase 4
- Access Program for Use of AMD3100 to Increase Peripheral Blood Stem Cells for Transplantation in Patients Who Have Failed Standard Therapy Stem Cell MobilizationApproved for marketingNCT00291811
- PhII One Label Non-Comparative Trial in Metastatic Hormone Refractory Prostate Cancer in Combination With PrednisoloneCompletedNCT00291005Phase 2
- Rasburicase for HyperuricemiaCompletedNCT00290992Phase 2
- Efficacy and Safety of Insulin Glulisine in Type 1 Diabetes MellitusCompletedNCT00290979Phase 3
- Randomized Multicenter Study Comparing Docetaxel Plus Cisplatin and 5-FU to Cisplatin Plus 5-FU in Advanced Gastric CancerCompletedNCT00290966Phase 2/3
- Evaluation of the Overall Survival of Meclinertant Versus Placebo After a First Line Chemotherapy With Cisplatin + EtoposideCompletedNCT00290953Phase 2/3
- Efficacy and Safety of Insulin Glulisine in Type 2 Diabetes MellitusCompletedNCT00290927Phase 3
- Glulisine Pre- and PostmealCompletedNCT00290043Phase 1
- ALFAURUS : A DB Randomized Parallel Group Study of Alfuzosin 10mg OD vs Placebo in the Management of AUR in Patients With a 1st Episode Due to BPHCompletedNCT00290030Phase 3
- A Double-blinded Evaluation of Safety and Efficacy of Hylaform and Hylaform Plus Compared to Zyplast.CompletedNCT00288470Not applicable
- Study Evaluating Rimonabant Efficacy in Insulin-Treated Diabetic Patients(ARPEGGIO)CompletedNCT00288236Phase 3
- Telithromycin in Acute Exacerbation of Chronic BronchitisTerminatedNCT00288223Phase 4
- Comparison of Safety and Immunogenicity of Pediacel™ and Infanrix™ IPV+Hib (Penta) Given in a 3 Dose Schedule in InfantsCompletedNCT00287092Phase 3
- Long-Term Safety Extension With SR57667B in Patients With Alzheimer's DiseaseCompletedNCT00285077Phase 2
- Study of the Effect of SR57667B in Patients With Alzheimer's DiseaseCompletedNCT00285025Phase 2
- AVE7688 in Patients With Mild to Moderate Blood PressureCompletedNCT00284128Phase 2/3
- Residual Effects of Zolpidem Tartrate Extended Release and Eszopiclone Vs PlaceboCompletedNCT00283790Phase 4
- APROVE : Irbesartan in HypertensionCompletedNCT00283036Phase 4
- Safety Study of MVA Smallpox Vaccine in HIV-positive Subjects Who Are Vaccinia NaiveTerminatedNCT00282581Phase 1
- Leflunomide in Rheumatoid ArthritisCompletedNCT00280644Phase 4
- Oxaliplatin in Unresectable Hepatocellular CarcinomaCompletedNCT00280618Phase 2
- ALF-ONE : ALFuzosin ONcE DailyCompletedNCT00280605Phase 4
- Docetaxel in the Treatment of Hormone Refractory Prostate CancerCompletedNCT00280098Phase 4
- Riluzole in Huntington's DiseaseCompletedNCT00277602Phase 3
- LISA-study : Levothyroxin in Nodular GoiterCompletedNCT00277589Phase 4
- Levofloxacin, Chronic Bacterial ProstatitisCompletedNCT00277511Phase 3
- MOSAIC - Multicenter International Study of Oxaliplatin/ 5FU-LV in the Adjuvant Treatment of Colon CancerCompletedNCT00275210Phase 3
- DILIPO (DILutIonal HyPOnatremia)CompletedNCT00274326Phase 3
- Induction Chemotherapy Comparing Taxotere® Cisplatin and 5-Fluorouracil (TPF) With Standard Cisplatin and 5-Fluorouracil (PF) Followed by Chemoradiation in Locally Advanced Head and Neck CancerCompletedNCT00273546Phase 3
- TELICAST : Telithromycin in Acute Exacerbations of AsthmaCompletedNCT00273520Phase 3
- EMINEM: Efficacy of Muscoril In NEck Myofascial SyndromesCompletedNCT00272532Phase 4
- Insulin Glargine in Type 1 Diabetes MellitusCompletedNCT00272090Phase 3
- Insulin Glargine in Type 2 Diabetes MellitusCompletedNCT00272077Phase 4
- ELEONOR STUDY: Insulin Glulisine in Type 2 Diabetes Mellitus.CompletedNCT00272064Phase 3
- XENOX - Evaluation of the Efficacy of Xaliproden in Reducing the Neurotoxicity of the Oxaliplatin + 5-FU/LV ChemotherapyCompletedNCT00272051Phase 3
- OPAL - Insulin Glulisine, Diabetes MellitusCompletedNCT00272012Phase 3
- Safety Study of Docetaxel/Cisplatin Induction Therapy Followed by Concurrent Chemoradiotherapy or Concurrent Chemoradiotherapy Followed by Consolidation Docetaxel/Cisplatin in NSCLC PatientsTerminatedNCT00271323Phase 2
- Efficacy Study on the Control of Blood Glucose Concentration in Type 1 Diabetic PatientsCompletedNCT00271284Phase 3
- Efficacy Study of GEMOX Combination and Vinorelbine in NSCL PatientsCompletedNCT00271271Phase 2
- Safety Study of Sodium Divalproate in Bipolar Disorder in AdolescentsCompletedNCT00271258Phase 3
- Effects of Ciclesonide MDI 50mg/Day and 200mg/Day (Ex-Valve) Once-Daily on Growth in Children With Mild Persistent AsthmaCompletedNCT00270348Phase 3
- Study to Compare Sevelamer Carbonate Powder to Sevelamer Hydrochloride Tablets in Patients With CKD on HemodialysisCompletedNCT00268957Phase 3
- Safety and Effectiveness Study of rhGAA in Patients With Advanced Late-Onset Pompe Disease Receiving Respiratory SupportCompletedNCT00268944Phase 3